NDC properties for "dabigatran etexilate 40 MG (as dabigatran etexilate mesylate 46.12 MG) Oral Pellet" (RxCUI 2590631)
About this data
The tables show NDC propoerties for dabigatran etexilate 40 MG (as dabigatran etexilate mesylate 46.12 MG) Oral Pellet with the RxCUI 2590631
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for dabigatran etexilate 40 MG (as dabigatran etexilate mesylate 46.12 MG) Oral Pellet (RxCUI 2590631)
| MMSL_CODE | CD39053 |
|---|---|
| RxCUI | 2590631 |
| VUID | 4042039 |
| Prescribable Synonym | dabigatran etexilate 40 MG Oral Pellet |
| RXNAV_STR | dabigatran etexilate 40 MG Oral Pellet |
| RxNorm Name | dabigatran etexilate 40 MG Oral Pellet |
| RxNorm Synonym | dabigatran etexilate 40 MG (as dabigatran etexilate mesylate 46.12 MG) Oral Pellet |
| Related queries | Interactions (for RxCUI 2590631) |
NDC Properties
no results for this query in NIH